Showing results (251-260 of 290) with videos related to
Sort By:
Pageof 29
Alimentary Pharmacology & Therapeutics|February 16, 2005
Oral methotrexate in ulcerative colitisJ R F Cummings, K R Herrlinger, S P L Travis, et al.Gut|June 2, 2005
Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's diseaseD A van Heel, S Ghosh, K A Hunt, et al.Gut|June 1, 1996
Predicting outcome in severe ulcerative colitisS P Travis, J M Farrant, C Ricketts, et al.Alimentary Pharmacology & Therapeutics|May 29, 2002
Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trialS A Mitchell, A S Mee, G D Smith, et al.Gut|May 13, 2003
Mobilisation of enterocyte fat stores by oral glucose in humansM D Robertson, M Parkes, B F Warren, et al.Human Pathology|November 1, 1985
Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitisW A Franklin, G B McDonald, H O Stein, et al.Tissue Antigens|October 5, 2010
Association of caspase-9 and RUNX3 with inflammatory bowel diseaseC Guo, T Ahmad, J Beckly, et al.Gut|July 1, 1983
Comparative study of pancreatic polypeptide (PP) secretion, endocrine and exocrine function, and structural damage in chronic alcohol induced pancreatitis (CAIP)A S Mee, L J Klaff, A H Girdwood, et al.Clinical and Experimental Immunology|May 1, 1976
Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitisA C Campbell, J M Skinner, I C Maclennan, et al.Gut|February 1, 1988
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centresS N Gyde, P Prior, R N Allan, et al.Pageof 29